StockVS

State Street Health Care Select Sector SPDR ETF (XLV) ETF 분석

Health

State Street Health Care Select Sector SPDR ETF

$148.51

$-1.38 (-0.92%)

최종 업데이트: 2026년 5월 26일

가격 이력

최신 뉴스

제3자 소스에서 제공된 뉴스입니다. 투자 조언이 아닙니다.

주요 보유 종목

# 종목코드 종목명 비중
1 LLY Eli Lilly and Co 14.68%
2 JNJ Johnson & Johnson 9.76%
3 ABBV AbbVie Inc 7.03%
4 MRK Merck & Co Inc 4.88%
5 UNH UnitedHealth Group Inc 4.63%
6 TMO Thermo Fisher Scientific Inc 3.88%
7 ABT Abbott Laboratories 3.39%
8 AMGN Amgen Inc 3.28%
9 ISRG Intuitive Surgical Inc 3.19%
10 GILD Gilead Sciences Inc 3.14%

분석

펀드 개요

State Street Health Care Select Sector SPDR ETF (XLV) is a specialized equity fund managed by State Street Investment Management that focuses exclusively on the healthcare sector. The fund currently oversees a substantial Total Assets figure of $38.60B, which indicates a large-scale operation with significant market capitalization and established popularity among institutional and retail participants. Although the Holdings Count is not publicly disclosed in the available data, the fund structure suggests exposure to a diversified basket of companies within the designated Health category. With an Expense Ratio of 0.1%, the fund operates with a low-cost structure, allowing a greater portion of gross returns to be retained by shareholders compared to higher-cost alternatives.

성과 분석

The current Yield stands at 1.7%, providing a steady stream of income for investors seeking regular cash flow from their equity portfolios. This income component is particularly relevant for those looking to balance capital appreciation with dividend income in a portfolio. The Year-to-Date Return has recorded a figure of -4.9%, reflecting the short-term market fluctuations experienced by the sector during the current calendar year. Over longer horizons, the 3-Year Average Return is 5.5%, while the 5-Year Average Return is 6.5%, demonstrating a consistent positive track record that helps smooth out recent annual volatility. The divergence between the negative YTD performance and the positive multi-year averages highlights the cyclical nature of the healthcare sector, where long-term compounding often outpaces short-term drawdowns. Additionally, the low Expense Ratio of 0.1% ensures that fees have a minimal drag on net returns, preserving more of the generated 5.5% and 6.5% average annual returns over the three and five-year periods respectively.

Price & Risk Profile

The 52-Week High price is recorded at $160.59, while the 52-Week Low is $127.35, defining the trading range within which the security has moved over the past year. This range illustrates the degree of price volatility inherent in the sector, showing that the price has experienced significant swings between its peak and trough levels. Given that the fund's current market value fluctuates between these two extremes, the price action suggests a moderate level of volatility relative to broader defensive sectors. The Beta value is listed as N/A in the available facts, meaning specific volatility metrics relative to the broader market index are not disclosed for this specific fund snapshot. Consequently, the overall risk profile must be assessed primarily through the lens of the wide 52-week price range and the recent YTD decline, rather than a standardized beta coefficient. The combination of a substantial asset base and a low expense ratio provides a stable foundation, though the recent negative return and wide price spread indicate that investors should monitor sector-specific risks carefully. The fund's performance metrics, including the 1.7% yield and multi-year positive returns, offer context for evaluating risk-adjusted returns within the health care industry landscape.

이 분석은 AI에 의해 생성된 것으로 정보 제공 목적으로만 사용되며 재정 조언으로 간주되어서는 안 됩니다. 데이터가 지연되거나 부정확할 수 있습니다. 투자 결정을 내리기 전에 항상 자체 조사를 수행하고 자격을 갖춘 재정 고문과 상담하십시오.

주요 통계

총 자산
$37.88B
비용 비율
0.08%
배당 수익률
1.72%
연초 대비 수익률
-5.33%
3년 평균 수익률
+6.23%
5년 평균 수익률
+5.49%

데이터는 yfinance를 통해 Yahoo Finance에서 제공됩니다. 매일 업데이트.

펀드 정보

카테고리
Health
펀드 패밀리
State Street Investment Management
거래소
PCX